GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Cash per Share

Tatva Chintan Pharma Chem (BOM:543321) Cash per Share : ₹20.97 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Tatva Chintan Pharma Chem's Cash per Share for the quarter that ended in Mar. 2024 was ₹20.97.


Tatva Chintan Pharma Chem Cash per Share Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Cash per Share Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash per Share
Get a 7-Day Free Trial 5.06 3.73 28.79 13.03 20.97

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.03 - 61.66 - 20.97

Tatva Chintan Pharma Chem Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Tatva Chintan Pharma Chem's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Tatva Chintan Pharma Chem's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem  (BOM:543321) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Tatva Chintan Pharma Chem Cash per Share Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines